Table 1. Disease-causing variants identified in patients with life-threatening COVID-19.
Gene | Inheritance | Genetic form | Genotype | Gender | Age [years] | Ancestry/residence | Outcome |
TLR3 | AD | Known | p.Ser339fs/WT | M | 40 | Spain | Survived |
TLR3 | AD | Known | p.Pro554Ser/WT | M | 68 | Italy | Survived |
TLR3 | AD | Known | p.Trp769*/WT | M | 77 | Italy | Survived |
TLR3 | AD | Known | p.Met870Val/WT | M | 56 | Colombia/Spain | Survived |
UNC93B1 | AD | New | p.Glu96*/WT | M | 48 | Venezuela/Spain | Survived |
TICAM1 | AD | Known | p.Thr4Ile/WT | M | 49 | Italy | Survived |
TICAM1 | AD | Known | p.Ser60Cys/WT | F | 61 | Vietnam/France | Survived |
TICAM1 | AD | Known | p.Gln392Lys/WT | F | 71 | Italy | Deceased |
TBK1 | AD | Known | p.Phe24Ser/WT | F | 46 | Venezuela/Spain | Survived |
TBK1 | AD | Known | p.Arg308*/WT | M | 17 | Turkey | Survived |
IRF3 | AD | Known | p.Glu49del/WT | F | 23 | Bolivia/Spain | Survived |
IRF3 | AD | Known | p.Asn146Lys/WT | F | 60 | Italy | Survived |
IRF7 | AR | Known | p.Pro364fs/p.Pro364fs | F | 49 | Italy/Belgium | Survived |
IRF7 | AR | Known | p.Met371Val/p.Asp117Asn | M | 50 | Turkey | Survived |
IRF7 | AD | New | p.Arg7fs/WT | M | 60 | Italy | Survived |
IRF7 | AD | New | p.Gln185*/WT | M | 44 | France | Survived |
IRF7 | AD | New | p.Pro246fs/WT | M | 41 | Spain | Survived |
IRF7 | AD | New | p.Arg369Gln/WT | M | 69 | Italy | Survived |
IRF7 | AD | New | p.Phe95Ser/WT | M | 37 | Turkey | Survived |
IFNAR1 | AR | Known | p.Trp73Cys/Trp73Cys | M | 38 | Turkey | Survived |
IFNAR1 | AR | Known | p.Ser422Arg/Ser422Arg | M | 26 | Pakistan/Saudi Arabia | Deceased |
IFNAR1 | AD | New | p.Pro335del/WT | F | 23 | China/Italy | Survived |
IFNAR2 | AD | New | p.Glu140fs/WT | F | 54 | Belgium | Survived |